These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 12049693

  • 1. [Clinical evolution of a cohort of patients with Graves-Basedow disease treated with metimazole].
    De Luis DA, Arconada A, Aller R, Cuéllar LA, Terroba MC, Martín Gil J.
    Med Clin (Barc); 2002 Jun 01; 118(20):777-8. PubMed ID: 12049693
    [Abstract] [Full Text] [Related]

  • 2. [Recurrence and prognostic factors after treatment with antithyroid agents in Graves-Basedow disease. Multicenter study in Northern Spain].
    Menéndez Torre E, Anda Apiñaniz E, Barbería Layana JJ, Valdés Gallego N, Rabal Artal A, Díaz-Cadórniga F, Santamaría Sandi J, Vázquez García JA.
    Rev Clin Esp; 2000 Feb 01; 200(2):69-73. PubMed ID: 10776037
    [Abstract] [Full Text] [Related]

  • 3. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole.
    Gumà M, Salinas I, Reverter JL, Roca J, Valls-Roc M, Juan M, Olivé A.
    J Clin Endocrinol Metab; 2003 May 01; 88(5):2141-6. PubMed ID: 12727967
    [Abstract] [Full Text] [Related]

  • 4. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA, Gross JL, Maia AL.
    J Clin Endocrinol Metab; 2001 Aug 01; 86(8):3488-93. PubMed ID: 11502768
    [Abstract] [Full Text] [Related]

  • 5. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F, González-Ortiz M, Durón H, Sánchez C.
    Rev Invest Clin; 2002 Aug 01; 54(4):307-10. PubMed ID: 12415954
    [Abstract] [Full Text] [Related]

  • 6. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L, Huot C, Lambert R, Deal C, Collu R, Van Vliet G.
    Clin Invest Med; 1999 Aug 01; 22(4):132-9. PubMed ID: 10497711
    [Abstract] [Full Text] [Related]

  • 7. The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial.
    Braga M, Walpert N, Burch HB, Solomon BL, Cooper DS.
    Thyroid; 2002 Feb 01; 12(2):135-9. PubMed ID: 11916282
    [Abstract] [Full Text] [Related]

  • 8. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A.
    N Engl J Med; 1998 Jan 08; 338(2):73-8. PubMed ID: 9420337
    [Abstract] [Full Text] [Related]

  • 9. A 6-year follow-up of a randomized prospective trial comparing methimazole treatment with or without exogenous L-thyroxine in Chinese patients with Graves' disease.
    Liu X, Qiang W, Liu X, Liu L, Liu S, Gao A, Gao S, Shi B.
    Exp Clin Endocrinol Diabetes; 2014 Nov 08; 122(10):564-7. PubMed ID: 25140995
    [Abstract] [Full Text] [Related]

  • 10. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F, Giovannetti C, Fessehatsion R, Tanda ML, Campomori A, Compri E, Rossi G, Ceccarelli C, Vitti P, Pinchera A, Bartalena L, Martino E.
    J Clin Endocrinol Metab; 2010 Jan 08; 95(1):201-8. PubMed ID: 19906789
    [Abstract] [Full Text] [Related]

  • 11. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
    Andrade VA, Gross JL, Maia AL.
    J Clin Endocrinol Metab; 1999 Nov 08; 84(11):4012-6. PubMed ID: 10566642
    [Abstract] [Full Text] [Related]

  • 12. [Basedow's disease. Individual therapy of is great significance].
    Hörmann R.
    MMW Fortschr Med; 2005 Sep 01; 147(35-36):47. PubMed ID: 16180573
    [No Abstract] [Full Text] [Related]

  • 13. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
    Nakazato N, Yoshida K, Mori K, Kiso Y, Sayama N, Tani JI, Nakagawa Y, Ito S.
    Thyroid; 1999 Aug 01; 9(8):775-9. PubMed ID: 10482369
    [Abstract] [Full Text] [Related]

  • 14. Preventing Graves' ophthalmopathy.
    Wiersinga WM.
    N Engl J Med; 1998 Jan 08; 338(2):121-2. PubMed ID: 9420345
    [No Abstract] [Full Text] [Related]

  • 15. Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13.
    Komiya I, Yamada T, Sato A, Kouki T, Nishimori T, Takasu N.
    J Clin Endocrinol Metab; 2001 Aug 08; 86(8):3540-4. PubMed ID: 11502776
    [Abstract] [Full Text] [Related]

  • 16. [Long-term follow up after antithyroid drug treatment in Graves' disease].
    Wille T, Müller B, Noth D, Bürgi U, Diem P.
    Praxis (Bern 1994); 2006 Jul 19; 95(29-30):1121-7. PubMed ID: 16916174
    [Abstract] [Full Text] [Related]

  • 17. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
    Wu G, Jie Y, Situ Y.
    Zhonghua Yi Xue Za Zhi; 2001 Mar 10; 81(5):274-5. PubMed ID: 11798886
    [Abstract] [Full Text] [Related]

  • 18. Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?
    Bogazzi F, Martino E, Bartalena L.
    J Endocrinol Invest; 2003 Feb 10; 26(2):174-6. PubMed ID: 12739747
    [No Abstract] [Full Text] [Related]

  • 19. Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.
    Pedro AB, Romaldini JH, Takei K.
    Neuroimmunomodulation; 2011 Feb 10; 18(1):45-51. PubMed ID: 20628263
    [Abstract] [Full Text] [Related]

  • 20. The outcome of 131I treatment in Graves' patients pretreated or not with methimazole.
    Pirnat E, Zaletel K, Gaberšček S, Hojker S.
    Hell J Nucl Med; 2011 Feb 10; 14(1):25-9. PubMed ID: 21512661
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.